Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Biotech
Novo Holdings assets shrink by 3rd as Novo Nordisk shares fall
Novo Holdings saw its assets shrink by a third last year as part of the fallout of Novo Nordisk’s nosediving share price.
James Waldron
Mar 12, 2026 7:15am
Galapagos took €228M hit from cell therapy wind-down
Feb 24, 2026 6:30am
Roche diagnostics biz nudges up 2% amid China drag
Jan 29, 2026 8:45am
Abbott shares sag as diagnostic, nutrition biz sales decline
Jan 23, 2026 8:05am
Lumexa Imaging IPO tallies $462.5M, doubling original target
Dec 15, 2025 9:40am
Century, Candel, MacroGenics call time on trials to save cash
Nov 13, 2025 10:15am
